Pai, P.-Y.; Wong, J.K.S.; Cui, Z.-Y.; Lin, Y.-Y.; Lee, S.-D.
Angiotensin II Receptor Blocker Irbesartan Enhanced SIRT1 longevity Signaling Replaces the Mitochondrial Biogenetic Survival Pathway to Attenuate Hypertension-Induced Heart Apoptosis. J. Cardiovasc. Dev. Dis. 2022, 9, 266.
https://doi.org/10.3390/jcdd9080266
AMA Style
Pai P-Y, Wong JKS, Cui Z-Y, Lin Y-Y, Lee S-D.
Angiotensin II Receptor Blocker Irbesartan Enhanced SIRT1 longevity Signaling Replaces the Mitochondrial Biogenetic Survival Pathway to Attenuate Hypertension-Induced Heart Apoptosis. Journal of Cardiovascular Development and Disease. 2022; 9(8):266.
https://doi.org/10.3390/jcdd9080266
Chicago/Turabian Style
Pai, Pei-Ying, James K. S. Wong, Zhen-Yang Cui, Yi-Yuan Lin, and Shin-Da Lee.
2022. "Angiotensin II Receptor Blocker Irbesartan Enhanced SIRT1 longevity Signaling Replaces the Mitochondrial Biogenetic Survival Pathway to Attenuate Hypertension-Induced Heart Apoptosis" Journal of Cardiovascular Development and Disease 9, no. 8: 266.
https://doi.org/10.3390/jcdd9080266
APA Style
Pai, P.-Y., Wong, J. K. S., Cui, Z.-Y., Lin, Y.-Y., & Lee, S.-D.
(2022). Angiotensin II Receptor Blocker Irbesartan Enhanced SIRT1 longevity Signaling Replaces the Mitochondrial Biogenetic Survival Pathway to Attenuate Hypertension-Induced Heart Apoptosis. Journal of Cardiovascular Development and Disease, 9(8), 266.
https://doi.org/10.3390/jcdd9080266
